Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
- Jun 18
- 2 min
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well‑Being: Findings from T21
- Jun 6
- 2 min
Prescribed Medicinal Cannabis for the Treatment of Chronic Pain Comorbid with Depression: Real World Evidence from Project Twenty21
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
- Dec 12, 2023
- 3 min
UK’s largest medical cannabis study announces new industry partners
- May 25, 2023
- 2 min
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
- May 5, 2023
- 2 min
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis
- Mar 23, 2023
- 2 min
Preliminary findings from T21 Australia
- Mar 20, 2023
- 2 min
Combating the stigma: a T21 success story
- Feb 24, 2023
- 2 min
Grow Pharma joins T21
- Feb 13, 2023
- 3 min
Parents and scientists back new study into benefits of cannabis-based medications for children with severe epilepsy
- Jan 24, 2023
- 1 min
Drug Science’s medical cannabis patient registry (T21) sees departure of Lyphe Group and introduces new pricing model
- Jan 16, 2023
- 4 min
Drug Science’s medical cannabis patient registry (T21) to continue for a fourth year
- Feb 8, 2022
- 2 min
Medical Cannabis study Project Twenty21 begins in Australia
- Jan 6, 2022
- 4 min
Project Twenty21 in 2022: A Message for Patients
- Sep 14, 2021
- 3 min
Project Twenty21 - September Update
- Aug 10, 2021
- 4 min
Project Twenty21 - August Update
- Jul 13, 2021
- 4 min
Project Twenty21 - July Update
- Jun 9, 2021
- 3 min
Project Twenty21 - June Update
- Mar 12, 2021
- 3 min
Project Twenty21 - March Update
- Mar 9, 2021
- 2 min
Statement Regarding Project Twenty21 and its Official Industry Partners